Jeanne Cunicelli (UPMC via Twitter)

UPMC ven­ture arm ear­marks $1B in­vest­ment in life sci­ences

UPMC En­ter­pris­es, which most re­cent­ly backed Were­wolf Ther­a­peu­tics, is now set­ting aside $1 bil­lion to de­vel­op new drugs, de­vices and di­ag­nos­tics.

Ini­tial­ly fo­cused on im­munother­a­pies for can­cer, trans­plan­ta­tion and ag­ing, the Uni­ver­si­ty of Pitts­burgh Med­ical Cen­ter’s (UPMC) ven­ture cap­i­tal arm has ex­pand­ed its fo­cus to in­clude reti­nal and res­pi­ra­to­ry dis­ease, au­toim­mune dis­eases and neu­roin­flam­ma­tion among oth­ers.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.